Even today vaccine(s) remains a mainstay in combating infectious diseases. Many yeast-based vaccines are currently in different phases of clinical trials. Despite the encouraging results of whole recombinant yeast and yeast display, the systematic study assessing the long-term stability of protein antigen(s) in yeast cells is still missing. Therefore, in the present study, I investigate the stability of heterologous protein antigen in the cellular environment of Saccharomyces cerevisiae through Escherichia coli surface protein (major curlin or CsgA). Present biochemical data showed that the stationary-phase yeast cells were able to keep the antigen stable for almost 1 year when stored at 2
INTRODUCTION
Vaccines remains an important and mainstay in preventing infectious diseases (Perrie et al. 2007; Black et al. 2010; Bachler et al. 2013) . Most of the presently licensed vaccine(s) involve deliberate administration of attenuated or killed pathogen (Shams 2005) . Conventional vaccine development regime involved mass culture of an associated or closely related organism and this hampered vaccine development against important infectious diseases including malaria and leprosy (Cox 1991; Scollard et al. 2006) . Apart from that, conventional vaccines suffered from various issues neatly summarized elsewhere (Pastoret 1999; Rubin et al. 2014; Narasimhan et al. 2015; Fang et al. 2016) .
The arrival of recombinant DNA technology and a parallel improvement in protein purification chemistry allows expression and purification of large quantities of heterologous protein(s) in almost all types of cells ranging from prokaryotes (e.g. Escherichia coli, Bacillus subtilis) to eukaryotes including yeast, insects, plants and animals. But professional working in concerned discipline chooses yeast as a model for expression of heterologous proteins for use in vaccine development for reasons mentioned elsewhere (Strathern, Jones and Broach 1982; Valenzuela et al. 1982; Rose and Harrison 1987; Broach, Pringle and Jones 1991; Gellissen and Hollenberg 1997; Walker 1998) . So far, yeast (mainly Saccharomyces cerevisiae and Pichia pastoris) emerges as the main workhorse for expression and purification of heterologous proteins with pharmaceutical value. As a result, many of the proteins expressed and purified from yeast are under different phases of clinical trials (Ardiani et al. 2010; Bilusic et al. 2014; Li et al. 2014) , and protein purified from yeast for the purpose of prophylactic vaccine (e.g. hepatitis B vaccine) is already in market (Valenzuela et al. 1982) .
Although peptide-based vaccines somehow overcome the issue associated with the conventional regime of vaccine development and application, the problem of poor immunogenic response, fast body clearance, an addition of adjuvant and protein stabilizer means a better alternative of both conventional and peptide-based vaccines is must (Aguilar and Rodriguez 2007; Purcell et al. 2007) . Apart from that, continuous maintenance of 2
• C-8
• C cold chain from point of manufacturing unit till endpoint user especially in resource-poor settings is a big challenge in presently available vaccines (Das 2004 .
Issues associated with conventional and peptide-based vaccine lead to the development of a novel strategy of using yeast in vaccine development which culminates into the use of whole recombinant yeast (WRY) and yeast display (YD) . Use of WRY and YD proved much better as these strategies do not involve protein purification, the addition of protein stabilizers and adjuvant (as yeast cell wall acts as natural adjuvant), particulate nature of yeast cells. Apart from that, yeast cells are efficiently taken up by antigen presenting cells including macrophages (Stubbs et al. 2001) and T cells (King et al. 2014 (King et al. , 2016 . Thus, use of WRY and YD appears very promising and, in several cases, WRY-based vaccine(s) have already reached various stages of clinical trials. For example, heat-killed whole recombinant budding yeast-based vaccine (GS-4774) against hepatitis B reached to phase II of clinical trials (Lok et al. 2016 ) while dead whole yeast was able to protect mice from pulmonary mucormycosis treated with diabetic ketoacidotic steroid (Luo et al. 2014) . Further, injecting killed recombinant yeast expressing hepatitis B virus protein was found safe and well tolerated in healthy subjects (Gaggar et al. 2014) and an oral vaccine against candidiasis was introduced using molecular display systems with S. cerevisiae (Shibasaki and Ueda 2016) . All these and similar studies from different labs across the globe clearly showed the merits and benefits of using WRY and YD as yeast-based vaccines over conventional or peptide-based vaccines.
Despite the positive results from different labs against different infectious diseases and cancer, a systematic study investigating long-term stability of protein antigens or immunogen in WRY is missing. This compelled me to investigate the longterm stability of heterologous proteins or antigens in the cellular environment of budding yeast. Our present data showed that protein antigens remain stable in yeast cells for up to a year when kept under refrigeration (i.e. at 2
• C-8 
MATERIALS AND METHODS

Strains, media and culture condition
Haploid wild-type budding yeast strain of BY4742 background (purchased from EUROSCARF, acc. no. Y10000) expressing E. coli CsgA-GFP (fusion protein) under GAP or glyceraldehydes-3-phosphate dehydrogenase promoter was used in the entire study. Primers used in amplification of curlin major from E. coli are (forward primer, PR1) ATGCGAATTCATGAAACTTTTAAAAGTAGCAGCAATTGC, (reverse primer, PR2) ATGCGGTACCGTA CTGATGAGCGGTCGCG and (GFP reverse primer, PR3) CGTCGCCGTCCAGCTCGACCAG, used in sequencing. Underlined nucleotides represent restriction site. Yeast genetic manipulations were performed as described elsewhere (Güldener et al. 1996; Longtine et al. 1998; Janke et al. 2004) . For amplification of CSGA, E. coli K-12 strain was purchased from ATCC (strain SMG123). GFP was amplified from plasmid purchased from addgene (plasmid # 21052, pESC-URA-ub-G76A-Rnq1-GFP).
Cloning and expression of the CsgA-GFP fusion protein
Escherichia coli surface protein curlin (CsgA-GFP) was cloned into yeast expression vector under constitutive GAP promoter (for overexpression). The nucleotide and amino acid sequence of CsgA are shown in Fig. S1A and Fig. S1B (Supporting Information), respectively. Cloning was performed in two steps. Escherichia coli CsgA ORF was PCR amplified from wild-type E. coli K-12 strain using the primers mentioned above (Fig S1C, Supporting Information) . PCR product was treated with EcoRI and KpnI restriction endonuclease in CutSmart buffer (from NEB) for 1 h at 37
• C and column purified. Parent plasmid with GFP was also treated with same restriction enzymes and gel elution was performed. Ligation was performed at 16
• C for overnight (using T4 DNA ligase from NEB) and ligation mix was transformed into E. coli competent cells and transformants were selected on LB plus ampicillin plate(s). Positive transformants were checked by sequencing using a reverse primer from GFP (mentioned above). Resulted plasmid p1 (Fig. S1E , Supporting Information) was treated with EcoRI and AgeI to release CSGA-GFP cassette (Fig. S1D , Supporting Information). Cassette was gel eluted and cloned into a plasmid having GAP promoter for overexpression. Final plasmid p2 (Fig S1F, Supporting Information) was digested with StuI, and digested product was transformed into wild-type haploid yeast strain (Güldener et al. 1996) . Positive transformants were selected on his − plate and expression of a fusion protein (CsgA-GFP) was checked by western blot using anti-GFP antibodies ( 
Induction of stationary phase in yeast cells
Stationary phase was induced and checked in yeast cells as explained previously (Martinez et al. 2004; Kumar and Srivastava 2016) and briefly described here. A single colony of a haploid strain expressing CsgA-GFP (E. coli surface protein) under constitutive (GAP or glyceraldehydes-3-phosphate dehydrogenase) promoter was inoculated in 5 mL YPD (1% yeast extract, 2% peptone and 2% dextrose) and the tube was incubated at 30 • C, 250 rpm for overnight growth. Next day, overnight grown culture was used to inoculate 50 mL YPD such that initial OD 600nm was around 0.2. Flasks were then incubated at 30 • C; 250 rpm till growth ceased, by checking OD 600nm of culture by spectrophotometer at regular interval of 24 h. The culture was regularly checked for any contamination and cell morphology.
Storage of cells
After checking culture for any contamination and calculating cell density, the cell suspension was transferred into a sterile eppendrof tube such that each tube received around 13 OD 600nm yeast cells. Tubes were then transferred into cardboard boxes one of which was stored in the refrigerator (2 • C-8
• C) and other was kept on shelves in a lab (23
. Note under both condition cells were stored in dark away from direct light and without agitation. Cell suspension (1 mL) was directly transferred into each tube.
Protein extraction
A known number of cells were resuspended in TCA (trichloroacetic acid) such that final concentration of TCA was 20% and cells were frozen at -80
• C for at least 1 h. After 1 h, tubes were taken out of deep freezer and thawed at room temperature. Tubes were centrifuged at 14 000 g for 8-10 min, and the supernatant was discarded. Resulted pellet was resuspended in 1 mL chilled 100% acetone using bath sonicator. Tubes were again centrifuged as above, and the supernatant was again discarded, and protein pellet was air-dried and resuspended in protein solubilization buffer (7 M Urea, 2 M Thiourea, 4% CHAPS) (Reddy et al. 2013) .
Heat killing of yeast cells
Stationary-phase yeast cells were taken and divided into two equal parts: one part was incubated in a water bath maintained at 56
• C for 1 h to kill or heat inactivated yeast cells (Haller et al. 2007 ) while other part was kept at room temperature. The same treatment was also performed with control normal cycling cells.
Western blots
Western blot was performed as described previously (Kumar et al. 2014) .
Buffer exchange, in solution digestion, iTRAQ labeling, LC-MS/MS, data acquisition and analysis
For comparing the level of CsgA in yeast cells, quantitative iTRAQ-based proteomic analysis was performed. Amount of protein in whole cell lysate was estimated using 2-D Quant Kit (from GE). An equal amount of whole cell lysate protein was labeled with iTRAQ reagent using the 4-plex kit (from AB SCIEX).
Rest procedure was performed as described previously. Data acquisition and analysis were performed as explained in detailed elsewhere (Reddy et al. 2015; Kumar and Srivastava 2016) . During analysis of MS/MS data using Spectrum Mill (Agilent), taxonomy was kept as E. coli.
Fluorescence microscopy
All the images were captured using the Zeiss Axio vision microscope using appropriate filters.
Accession number
The nucleotide sequence of a gene cloned in this study was deposited in Genebank with the following accession number MH264502.
RESULTS
The basic logic behind the study and workflow
Over the last two to three decades, more than 400 papers (including research articles, reviews, case reports) appear which showed the utility of yeast species for expression and purification of heterologous proteins for vaccines (both prophylactic and therapeutic), and other pharmaceutical application. Further to make the process more rapid, robust and to cut down the cost involved in protein purification, use of WRY and YD appeared promising. Many labs already showed the usefulness of WRY and YD in development of a yeast-based vaccine(s). But the longterm stability of expressed immunogen (both in WRY and YD) remains elusive. Further, a systematic study evaluating the effect of temperature on the long-term stability (here stability means the complete amino acid sequence of the expressed protein) of heterologous proteins is also missing. Therefore, in the present study, I investigate the stability of heterologous protein via major curlin (E. coli surface protein, CsgA-GFP) in the cellular environment of S. cerevisiae, with the assumption that crowded cellular environment will minimize the effect of heat or temperature, pH change which otherwise fasten the process of protein degradation (Eggers and Valentine. 2001; Ghaemmaghami and Oas. 2001; McGuffee and Elcock. 2010) . Curlin is a component of bacterial fimbriae, structure important for bacterial attachment to another surface. Homologs of curlin have been already reported in a number of bacterial species and curlin was also detected in surrounding medium (Loferer et al. 1997; Olsen et al. 1998) .
I further study the effect of temperature on the long-term stability of heterologous protein as antigen and the basic workflow of the present study are shown in Fig. 1 . Compared to other phases or stages, stationary-phase cells are better in copping the temperature fluctuations which is important in the stability of expressed antigen(s) or immunogen(s) (Werner-Washburne et al. 1993) .
Induction of stationary-phase storage of samples
Positive transformants were patched on fresh YPD plate and plate was incubated at 30
• C till sufficient biomass appears on the plate. These patches were used for inoculating 5 mL YPD and tubes were incubated at 30 • C, 250 rpm for overnight growth. This overnight grown culture was used for inoculation of 50 mL YPD (in 250 mL flask) such that initial OD 600nm was close to 0.200. Flasks were incubated at 30
• C, 250 rpm and cell density was checked after every 24 h ( Fig. 2A) till growth ceases and cell entered stationary phase (almost all cells become round) as confirmed by cell morphology (round cells) (Kumar and Srivastava 2016) , and cell viability assay (Fig. 2C) as it is known that stationary-phase cell can remain viable for extended period even in the absence of nutrients (Kumar and Srivastava 2016) and FACS analysis (Fig. 2B) as stationary-phase cells arrested at G 1 (Kumar and Srivastava 2016) . Apart from that stationary phase was also checked by detecting Spg4-HA (stationaryphase gene 4) which are present in cells only under stationary phase (data not shown) (Kumar and Srivastava 2016). Thus, stationary-phase nature of cells was confirmed by different ways before cells were stored for a period of 1 year or longer.
Stability of CsgA-GFP fusion protein
From each of three flasks, 1 mL of cell suspension was transferred into separate sterile eppendrof tubes such that each tube received around 13 OD 600nm of yeast cells. After dispensing cell suspension half tubes were stored at 2 • C-8
• C and remaining half at 23
• C-25
• C (storage condition is described in materials and methods section). Then after every 1 month, three tubes each from 2-8
• C and 23-25
• C were taken out and OD 600nm were measured till the end of 14 months. Measurement of OD 600nm over the year showed that there is a gradual decrease in OD 600nm (Fig. 3A) , suggesting the cells may be dying. At the end of the 14 month, final OD 600nm of cells in tubes comes down close to 4.0. In Fig. 3A , data are shown only for one set, while the experiment was performed three times, and all three set followed the same trend. Further, it was observed that pace with which OD 600nm decreases was more in tubes stored at 23
• C compared to those stored at 2 • C-8
• C although the overall difference in OD 600nm after 1 year was insignificant. Apart from that we also observed the sharp difference in cell morphology after 1 year (Fig. 3B) . The morphology of cells stored under refrigerated condition (Fig. 3B , middle panel) was more like to normal cycling cells used as control (Fig. 3B , left panel) compared to those stored at room temperature for a year (Fig. 3B, right panel) . Present microscopic data showed that more number of cells lose their intact nature when stored at room temperature. After observing and comparing the morphology of cells stored at two different conditions, we check the level of the CsgA-GFP fusion protein in those cells by western blot. Protein in whole the cell lysate was extracted as described in the material and methods section, and proteins were resolved on 10% SDS-PAGE. Proteins were transferred on to PVDF membrane and the fusion protein was detected using anti-GFP antibodies ( Fig. 3C  and D) . Present western blot data showed that stationary-phase yeast cells were able to keep fusion protein (CsgA-GFP or curlin) intact for a period of 1 year under both the conditions of storage. To give an idea about the nature of whole cell lysate, the complete image of Ponceau S stained blot is also provided below their respective western blot image ( Fig. 3E and F for blot image shown in Fig. 3C and D, respectively) . Specificity of anti-GFP antibodies was checked separately (Fig. S1G, Supporting Information) .
The intensity of bands in western blot image in Fig. 3C and D was calculated using Image J software. The histogram in Fig. 3G and H showed that intensity of bands (and therefore level of the fusion protein) is approximately half in cells stored for 1 year both at 2
• C-8 • C and 23
• C compared to normal cycling cells used as a control for comparison. Thus, combined results of western blot and histogram showed that level of fusion proteins is significantly low when the comparison was made on the number of cells, although heterologous fusion protein remains stable at both the temperatures of storage. I further compare the level of a fusion protein between the cells stored at 2
• C-8 • C to those stored at 23
• C, and present western blot data suggest that level of a fusion protein is more in cells stored at 2 • C-8
• C compared to those at 23 • C-25
• C (Fig. 4A ).
Complete blot image for the Fig. 4A is shown in Fig. 4B . It is important to mention that western blot data shown so far in Figs  3 and 4, proteins were normalized based on cell numbers rather on absolute protein quantification. The intensity of bands was calculated using Image J software, and histogram showing relative intensities of bands in Fig. 4A is shown in Fig. 4C . Similar to the previous comparison, the level of fusion protein is approximately half in cells stored at 23
Further to get a better idea about the relative abundance of a fusion protein in cells stored at two different conditions, the protein concentration in cell lysate was calculated and an equal amount of protein was desalted, digested with trypsin and resulted peptides were labeled with iTRAQ reagents. Present iTRAQ (Ross et al. 2004 ) based quantitative proteomics showed that the level of curlin protein was more in cells stored under refrigerated conditions compared to those which were stored at room temperature (Fig. 4D) . Present iTRAQ data also confirmed and validated the western blot data. Just like western blot ( Fig. 4A and C) , iTRAQ-based quantitative analysis also showed an increased amount of curlin protein (Fig. 4D ) in whole cell lysate from cells stored under refrigerated condition compared to those stored at room temperature. In the present study, cell lysate from refrigerated cells was labeled with 115, 117 and those at room temperature with 114, 116 labels. It is important to mention that essentially same whole cell lysate was used in both western blots and the iTRAQ experiment.
I further compare the level of CsgA-GFP using western blot after normalizing protein on the basis of protein quantification (like the iTRAQ experiment, mentioned above) and results of western blot were in accordance with iTRAQ data (data not shown).
Effect of heat inactivation on the stability of fusion protein in yeast cells
After comparing the level of a fusion protein in cells stored at 2
• C and 23
• C-25 • C (above section), I further compare the stability of fusion protein in control and heat inactivated cells as yeast cells are heat inactivated before injecting into clinical subjects. First I check the effect of heat inactivation on the stability of fusion protein in control cycling cells and present western blot data showed that level of fusion protein remains essentially same in control and heat inactivated cells (Fig. 5B , 1-3 control cycling cells, 4-6 cycling cells heat inactivated). Heat inactivation was performed by incubating cells in a water bath maintained at 56
• C for 1 h (Haller et al. 2007) . Present western blot data showed that heat inactivation or heat killing of yeast cells does not affect the stability of fusion protein. Similar results were obtained for stationary phase (SP) cells (Fig. 5B , 7-9 stationary phase or SP control cells, 10-12 SP heat-inactivated cells). Protein loading is shown through Ponceau S stained blot. For this experiment protein was normalized on the basis of protein quantification by Bradford (Bradford. 1976) . Further purified protein (GFP) stored at -20 • C for more than a year (previous lab stock) was also used as control (Fig. 5A) . In each well, 2 μg purified GFP was loaded in triplicate. Loading of purified GFP is shown through Ponceau S blot. Present western blot showed that fusion protein remains intact in all the cases and heat inactivation does not affect protein stability and this observation is well supported by the previous study which showed that the magnitude of immune response raised by WRY is independent of live or dead nature of yeast cells (Franzusoff et al. 2005) . We further checked the effect of heat inactivation on cell viability, and our present data showed that all cells die on heat inactivation at 56
• C for 1 h (Fig. 5D ) compared to control untreated cells (Fig. 5C ).
Combined together the western blot data (Fig. 5B ), viability test ( Fig. 5C and D) showed that cells lose viability on heat treatment at 56
• C for 1 h but the protein stability remains unaffected.
Viability of stationary-phase cells
Studies from different labs in past and our own previous study (Kumar and Srivastava 2016) showed that stationary-phase yeast cells retain the viability for extended periods even in absence of nutrients, and therefore we checked the viability of cells after 1 year. Cell viability was checked by plating around 300 cells on YPD plates. The platting assay showed that almost all cells lose viability after 1 year irrespective of the temperature of storage ( Fig. 6A and B) . Almost all cells die after 1 year whether they were stored at 2 • C-8
• C (Fig. 6B ) or stored at 23
• C (Fig. 6A) .
Results of platting assay were further confirmed by checking the viability by trypan blue staining, and results of trypan blue staining are in accordance with that of platting assay (Fig. 6C ).
The present result showed that although cells die, still fusion protein remains intact suggesting that viability is not essential for the stability of the protein and this observation is in accordance with the above result where protein remains stable even on heat inactivation of cells.
DISCUSSION
In general, peptide-based vaccines overcome many issues associated with the conventional regime of vaccine development as mentioned in the introduction section. But peptide-based vaccines are far away from ideal one, and stability of peptide immunogens is an important concern and challenge. However, very few studies are available which assess the effect of temperature on long-term storage of peptide vaccines. For example, a peptide retains its conformation for a week when incubated at 45
• C. ESAT651-70-Q11 showed strong immunogenic response even after storage at 45
• C for up to 6 months (Sun et al. 2016) .
Similarly, in another study, it was observed that mixtures of up to 12 peptides remain stable for up to 5 years when stored at -20 Chianese-Bullock et al. 2009 ). Another study reported that anionic gold nanoparticles and PEG (polyethylene glycol) at the concentration of10 −8 -10 −6 M and 10 −7 -10 −4 M, respectively, increased the half-life of a GFP expressing adenovirus from ∼48 h to 21 days at 37
• C (Maria et al. 2016) . All these studies showed that peptide-based vaccines cannot be stored at room temperature for long period and must require deep freeze (-20 • C or -80 • C) which is an important challenge in developing countries (Das 2004; Chen and Kristensen 2009 ). Because of this, the introduction of new thermally stable vaccines that do not rely heavily on the cold chain has become an important goal (Chen and Kristensen 2009; Kristensen et al. 2011) . Despite this many of the peptide-based vaccines are in different phases of clinical trials (Li et al. 2014) . Application of WRY and YD clearly overcome many of the limitations associated with conventional and peptide-based vaccines. And many labs have already shown the encouraging results involving WRY or YD (Haller et al. 2005; Schiff et al. 2007; Chaft et al. 2014; Heery et al. 2015; Hudson et al. 2016) . All these and similar studies clearly showed the merits of using WRYbased vaccines. Although several studies are available which investigate the effect of a different temperature on the stability of peptide-based vaccine over a different period of storage, only one study appeared recently which investigate the amount and the stability of expressed proteins in WRY for a period of 6 months (Wang et al. 2018) . Further, the same study also showed the way for the quantification of heterologous proteins that remain in cells even after a year of incubation can be quantified (Wang et al. 2018) .
Still the study which investigates the stability of heterologous protein in WRY for period of year or longer was still missing and therefore this present work tried to fill that important gap in our understanding related to effect of temperature on morphology of yeast cells, stability and level of heterologous proteins in cellular environment of yeast over a period of a year or more. Although, the present study showed that the heterologous protein expressed in yeast remains intact but makes no comment about the actual amount of antigens that remain in total cell mass even after 1 year (logic for checking stability is shown through Fig. 7A ). As far as the amount of expressed protein is concerned, incorporating the multi-copy of heterologous genes as described elsewhere (Moon et al. 2016) can take care of this. An important issue which needs to be addressed is whether the level of antigens which remain in yeast cells (over a period of 1-2 years at the different temperature) will be able to raise an optimum immune response. The number of cells that need to be stored at the first hand so that enough amount of antigens remains even after a year of storage for optimum immune response needs to be workout. But the present study clearly makes a point that WRY-based vaccine can be transported and distributed even in the absence of cold chain as stationaryphase cells are robust enough to keep antigens stable at room temperature for the duration of transportation and distribution which is not the case with the peptide-based vaccine in the absence of protein stabilizers. The present study also showed that yeast cells cannot be stored too long in the liquid medium even under the refrigerated condition and therefore ways must be devised which allows long-term storage of cells at room temperature (Fig. 3A) . Although the present way of checking the stability of a heterologous protein in WRY is good enough which mainly rely on the intact C or N-terminal tag and molecular weight markers, just position of the fusion protein at expected position (relative to protein marker) and one terminal tagging is not the best strategy. Therefore, I also proposed a simple strategy for confirming the completeness of heterologous protein in WRY. This strategy involved tagging of both N and C terminal of heterologous protein with two different tags (Fig. 7B) , and detection of the fusion protein with both the tags and at the same place in blot informs that expressed protein is intact from N to C terminus. This strategy was taken from YD where the protein of interest is tagged at both N and C terminal (Boder and Wittrup1997) . Bands detected at two different positions when detected using antibodies against N and C terminal tags suggested cleavage or degradation of the heterologous protein.
In conclusion, it can be said that soon yeast-based vaccine will be a reality and strategy like WRY and YD will be really crucial in realizing the full potential of the yeast-based vaccine. The cellular environment of yeast appears suitable for keeping the immunogen intact for a long period when stored under a refrigerated condition or at room temperature. Since OD 600nm of cells decreases over period of storage, it is important to study whether the amount of immunogen in cells will be enough to raise a required immune response. But results of present work will surely encourage more studies in this direction and it will be interesting to study the stability of expressed immunogen at an elevated temperature close to 37
• C-43
• C which is common in tropical countries of Africa and Asia which require vaccine badly. Again, it will be of utmost importance to find out the ways to store immunogen in the cellular environment for at least 1-2 years even when cells are stored at elevated temperature (37 • C-
43
• C). But the present study clearly showed that WRY-based vaccine can be transported even under the normal condition without the need for a continuous chain of refrigeration which is itself of great importance.
